Illinois Hospital Report Card

and Consumer Guide to Health Care

Endeavor Elmhurst Hospital

Patient Safety - CDI & MRSA

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Facility-wide Healthcare Facility Onset Incidence Rates for CDI and MRSA are presented below. These rates are based on results of laboratory tests that were obtained on or after day four of an inpatient stay and do not consider presence or timing of clinical signs or symptoms. The Standardized Infection Ratio (SIR) is presented, which is a summary measure used to determine if rates of CDI and MRSA bloodstream infections are statistically different from the national average. Statewide summaries of CDI and MRSA data arranged by hospital are also included. Note: Starting with 2016 data, new methods for risk adjustment were used.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
115	Complete Reporting: Results based on 6 months reporting due to statistical modelling exclusion criteria
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted

Healthcare Facility Onset Incidence Rate	Result	SIR
Methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections Q1 2023 - Q4 2023 Result 2 infections, 88647 patient days Rating SIR: 0.65	2 infections, 88647 patient days	0.65
Description Methicillin-resistant Staphylococcus aureus infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 4 infections, 85913 patient days Rating SIR: 1.18	4 infections, 85913 patient days	1.18
Q1 2021 - Q4 2021 Result 1 infections, 83092 patient days Rating SIR: 0.33	1 infections, 83092 patient days	0.33
Q1 2020 - Q4 2020 Result 3 infections, 80907 patient days Rating SIR: 0.91	3 infections, 80907 patient days	0.91
Q1 2019 - Q4 2019 Result 0 infections, 78448 patient days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 78448 patient days ¹¹⁷	0.00 ¹¹⁷
Q1 2018 - Q4 2018 Result 2 infections, 66111 patient days Rating SIR: 0.82	2 infections, 66111 patient days	0.82
Q1 2017 - Q4 2017 Result 1 infections, 67852 patient days Rating SIR: 0.47	1 infections, 67852 patient days	0.47
Q1 2016 - Q4 2016 Result 0 infections, 72448 patient days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 72448 patient days ¹¹⁷	0.00 ¹¹⁷
Q1 2015 - Q4 2015 Result 0 infections, 37431 patient days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 37431 patient days ¹¹⁷	0.00 ¹¹⁷
Q1 2014 - Q4 2014 Result 2 infections, 64549 patient days Rating SIR: 0.70	2 infections, 64549 patient days	0.70
Q1 2013 - Q4 2013 Result 1 infections, 59816 patient days Rating SIR: 0.38	1 infections, 59816 patient days	0.38
Q1 2012 - Q4 2012 Result 0 infections, 58657 patient days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 58657 patient days ¹¹⁷	0.00 ¹¹⁷
Q1 2012 - Q2 2012 Result 0 infections, 31498 patient days Rating SIR: 0.00	0 infections, 31498 patient days	0.00
Clostridioides difficile infections (CDI) Q1 2023 - Q4 2023 Result 10 infections, 86705 patient days Rating SIR: 0.13	10 infections, 86705 patient days	0.13
Description Clostridium difficile infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 19 infections, 84012 patient days Rating SIR: 0.18	19 infections, 84012 patient days	0.18
Q1 2021 - Q4 2021 Result 17 infections, 81113 patient days Rating SIR: 0.15	17 infections, 81113 patient days	0.15
Q1 2020 - Q4 2020 Result 15 infections, 78847 patient days Rating SIR: 0.15	15 infections, 78847 patient days	0.15
Q1 2019 - Q4 2019 Result 20 infections, 74611 patient days Rating SIR: 0.25	20 infections, 74611 patient days	0.25
Q1 2018 - Q4 2018 Result 20 infections, 66111 patient days Rating SIR: 0.30	20 infections, 66111 patient days	0.30
Q1 2017 - Q4 2017 Result 41 infections, 67852 patient days Rating SIR: 0.77	41 infections, 67852 patient days	0.77
Q1 2016 - Q4 2016 Result 60 infections, 72448 patient days Rating SIR: 1.02	60 infections, 72448 patient days	1.02
Q1 2015 - Q4 2015 Result 29 infections, 21804 patient days ¹¹⁵ Rating SIR: 1.77 ¹¹⁵	29 infections, 21804 patient days ¹¹⁵	1.77 ¹¹⁵
Q1 2014 - Q4 2014 Result 49 infections, 60549 patient days Rating SIR: 1.39	49 infections, 60549 patient days	1.39
Q1 2013 - Q4 2013 Result 33 infections, 56420 patient days Rating SIR: 0.69	33 infections, 56420 patient days	0.69
Q1 2012 - Q4 2012 Result 35 infections, 49627 patient days Rating SIR: 0.84	35 infections, 49627 patient days	0.84